Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies
暂无分享,去创建一个
W. König | W. Linz | F. Hock | B. Schölkens | S. Henke | G. Breipohl | J. Knolle | U. Albus | W. Konig | K. Wirth | B. Scholkens | H. Alpermann | H. Anagnostopoulos
[1] W. König,et al. Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studies , 1991, British journal of pharmacology.
[2] N. Rhaleb,et al. New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization. , 1990, Trends in pharmacological sciences.
[3] H. Vetter,et al. Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism. , 1990, European journal of pharmacology.
[4] K. Hargreaves,et al. Suppression of carrageenan-induced hyperalgesia, hyperthermia and edema by a bradykinin antagonist. , 1989, European journal of pharmacology.
[5] R. King,et al. SYNERGISTIC POTENTIATION BY CAPTOPRIL AND PROPRANOLOL OF BRADYKININ‐INDUCED BRONCHOCONSTRICTION IN THE GUINEA‐PIG , 1989, Clinical and experimental pharmacology & physiology.
[6] S. G. Farmer,et al. Antagonists of B2 bradykinin receptors , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] J. Vane,et al. Kinins act on B1 or B2 receptors to release conjointly endothelium‐derived relaxing factor and prostacyclin from bovine aortic endothelial cells , 1989, British journal of pharmacology.
[8] F. Lembeck,et al. Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation , 1989, British journal of pharmacology.
[9] P. Dieppe,et al. A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis. , 1989, Annals of the rheumatic diseases.
[10] F. V. Defeudis,et al. Bradykinin‐antagonists: Therapeutic perspectives , 1989 .
[11] J. Joris,et al. Bradykinin is increased during acute and chronic inflammation: Therapeutic implications , 1988, Clinical pharmacology and therapeutics.
[12] S. Snyder,et al. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[13] K. Chung,et al. Inflammatory mediators and asthma. , 1988, Pharmacological reviews.
[14] D. Proud,et al. Kinin formation: mechanisms and role in inflammatory disorders. , 1988, Annual review of immunology.
[15] F. Lembeck,et al. Effect of bradykinin antagonists on bradykinin‐induced plasma extravasation, venoconstriction, prostaglandin E2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit , 1987, British journal of pharmacology.
[16] R. Zusman. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] S. Snyder,et al. Antinociceptive effects of bradykinin antagonists. , 1987, European journal of pharmacology.
[18] R. Busse,et al. Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells. , 1987, European journal of pharmacology.
[19] D. Proud,et al. Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. , 1987, The Journal of clinical investigation.
[20] S. Snyder,et al. Two bradykinin binding sites with picomolar affinities. , 1986, The Journal of pharmacology and experimental therapeutics.
[21] W. König,et al. Atriopeptin III induces endothelium-independent relaxation and increases cGMP levels in rabbit aorta. , 1986, Klinische Wochenschrift.
[22] R. Tsien,et al. A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.
[23] J. Stewart,et al. Competitive antagonists of bradykinin , 1985, Peptides.
[24] R. Chapman,et al. Effect of propranolol on pulmonary function and bronchoconstrictor responsiveness in guinea pigs and rats. , 1985, Pharmacological research communications.
[25] D. Regoli. Neurohumoral regulation of precapillary vessels: the kallikrein-kinin system. , 1984, Journal of cardiovascular pharmacology.
[26] D. Regoli,et al. Pharmacology of bradykinin and related kinins. , 1980, Advances in experimental medicine and biology.
[27] J. Kreisberg,et al. Stimulation of arachidonic acid metabolism in rat kidney mesangial cells by bradykinin, antidiuretic hormone, and their analogues. , 1983, Prostaglandins, leukotrienes, and medicine.
[28] R Y Tsien,et al. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator , 1982, The Journal of cell biology.
[29] H. Coleridge,et al. Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.
[30] J. Mcgiff,et al. Prostaglandin Synthesis by Bovine Mesenteric Arteries and Veins , 1975, Circulation research.
[31] D. L. Wilhelm. Chapter 8 – CHEMICAL MEDIATORS , 1973 .
[32] E. G. Erdös,et al. Bradykinin, Kallidin and Kallikrein , 1970, Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie.
[33] D. L. Wilhelm. Chemical Mediators. I , 1965 .
[34] W. Feldberg,et al. The action of peptides on the adrenal medulla. Release of adrenaline by bradykinin and angiotensin , 1964, The Journal of physiology.
[35] Van Rossum Jm. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. , 1963 .
[36] C A WINTER,et al. Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.